Hello. Hoping someone may be able to help me find the prior/historical ISMP Pediatric assessment materials. Appreciate any information!

Our electronic health record (EHR) currently requires patient reverification (patient armband scanning) on the medication administration record (MAR) after 10 minutes. Our EHR does not provide any recommendations regarding this setting, but 10 minutes is the default if a value is not provided.

Our health system recently decided to implement a practice change where dorsogluteal injections are no longer allowed. Since then, nursing has reached out on several occasions asking for clarification/confirmation on appropriate, med-specific alternate administration sites. The literature surrounding the risk of adverse events secondary to dorsogluteal administration appears mixed.

Hello all,
Has anyone ended up turning off interoperability for specific units and if so for what reasons?
We are a Cerner/Plum site and are encountering workflow issues with certain areas, and there is concern that interop could result in errors.
Thanks for you feedback!
Leah Cochran, PharmD, BCPS

Can anyone share their tubing change practice for Y-sited SMOFlipids? The lipids expire after 12 hours, but is a 12 hour tubing change also performed at your facility?

Do any organizations utilize BCMA in the OR? If yes, any pearls for implementation? If not, what were the barriers?
Thanks in advance!

I'm conducting an internal review after identifying recent cases of septic arthritis following intra-articular corticosteroid injections.

Given a prior small cluster of injection associated complications, we are evaluating potential product, process, and technique factors.

Hello,

Our institution is evaluating the safety of polysorbate 80 in parenteral medications. While the excipient is used in many products (including foods, lotions, makeup, etc), there are concerns about parenteral administration and the risk for severe hypersensitivity reactions.

The excipient functions as an emulsifier or solubilizing agent and may be required to keep some medications in solution (e.g. docetaxel). For other parenteral medications, inclusion of polysorbate 80 varies by manufacturer.

Conflicting literature exists regarding the use of chlorhexidine for VAP prevention. Per SHEA/IDSA/APIC Practice Recommendation, oral care with chlorhexidine is not recommended.

1. Is your institution currently using chlorhexidine for VAP prevention?
2. If not, please provide what product you are currently using?

Hello,

How does your organization document lidocaine dosing? Our anesthesiologists document lidocaine in milligrams, but in our meditech EMR, we document in mLs.

Are other places transitioning to dosing in milligrams?

Thanks,

Annie